Swedish Orphan Biovitrum AB (publ) (SOBI.ST). Follow. Compare. 294.40 +5.80 ... Market Cap. 98.85B. Enterprise Value. 115.17B. Trailing P/E. 46.18. Forward P/E.
Market Cap. Orexo AB, -3.06%, kr565.18M. Abliva AB, 22.71%, kr360.96M. Active Biotech AB, 0.30%, kr179.42M. Vivesto AB, 1.51%, kr144.73M. Advertisement ...
Market cap (Mn). 100,000.09. Best bid. 282.00. Best offer. 282.40. Symbol ... © Swedish Orphan Biovitrum AB (publ) Reg. no. 556038-9321. About. At a glance.
Swedish Orphan Biovitrum AB (publ) (SWOBY). Follow. Compare. 15.40 0.00 (0.00 ... Market Cap. 8.90B. Enterprise Value. 10.67B. Trailing P/E. 46.35. Forward P/E.
Key statistics On Friday, Swedish Orphan Biovitrum AB (publ) (SOBI:STO) closed at 280.00, -7.28% below its 52-week high of 302.00, set on Feb 01, 2024.
People also search for
We're maintaining our SEK 343 fair value estimate for Swedish Orphan Biovitrum following solid second-quarter results (12% revenue growth, 28% adjusted EBITA ...
MARKET CAP. 104.323B. DAY RANGE. 287.00–295.00. 52 WEEK RANGE. 189.03–302.00. Key ... Swedish Orphan Biovitrum AB. Mats Peter Lek. Employee Representative.
Swedish Orphan Biovitrum AB Stock ; Mean consensus. BUY ; Number of Analysts. 10 ; Last Close Price. 280 SEK ; Average target price. 328.3 SEK ; Spread / Average ...
Market Cap: 98,086.55. Forward P/E: 28.64. Dividend Yield: 0.00. Key Statistics ... Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company.
End of year Market Cap ; 2018, $5.80 B · 58.26% ; 2017, $3.66 B · 15.88% ; 2016, $3.16 B · -26.16% ; 2015, $4.28 B · 56.91%.
Missing: ab | Show results with:ab